| Shin, Daniel Sanghoon; Zaretsky, Jesse M; Escuin-Ordinas, Helena et al. (2017) Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations. Cancer Discov 7:188-201 |
| Zaretsky, Jesse M; Garcia-Diaz, Angel; Shin, Daniel S et al. (2016) Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma. N Engl J Med 375:819-29 |
| Ribas, Antoni; Shin, Daniel Sanghoon; Zaretsky, Jesse et al. (2016) PD-1 Blockade Expands Intratumoral Memory T Cells. Cancer Immunol Res 4:194-203 |
| Hsu, Melody; Sedighim, Shaina; Wang, Tina et al. (2016) TCR Sequencing Can Identify and Track Glioma-Infiltrating T Cells after DC Vaccination. Cancer Immunol Res 4:412-418 |
| Shin, Daniel Sanghoon; Ribas, Antoni (2015) The evolution of checkpoint blockade as a cancer therapy: what's here, what's next? Curr Opin Immunol 33:23-35 |
| Hu-Lieskovan, Siwen; Mok, Stephen; Homet Moreno, Blanca et al. (2015) Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF(V600E) melanoma. Sci Transl Med 7:279ra41 |
| Larson, Sarah; De Oliveira, Satiro N (2014) Gene-modified hematopoietic stem cells for cancer immunotherapy. Hum Vaccin Immunother 10:982-5 |
| Hu-Lieskovan, Siwen; Robert, Lidia; Homet Moreno, Blanca et al. (2014) Combining targeted therapy with immunotherapy in BRAF-mutant melanoma: promise and challenges. J Clin Oncol 32:2248-54 |
| Drake, Justin M; Graham, Nicholas A; Lee, John K et al. (2013) Metastatic castration-resistant prostate cancer reveals intrapatient similarity and interpatient heterogeneity of therapeutic kinase targets. Proc Natl Acad Sci U S A 110:E4762-9 |
| Toy, Gerald; Austin, Wayne R; Liao, Hsiang-I et al. (2010) Requirement for deoxycytidine kinase in T and B lymphocyte development. Proc Natl Acad Sci U S A 107:5551-6 |
Showing the most recent 10 out of 15 publications
